Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
| Report ID | 91027 |
| Drug Identification Number | 02139510 |
| Brand name | SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | Sodium Chloride Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-08-06 |
| Estimated end date | 2019-08-30 |
| Actual end date | 2019-10-01 |
| Shortage status | Resolved |
| Updated date | 2020-01-16 |
| Company comments | Available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-01-16 | French | Compare |
| v2 | 2020-01-16 | English | Compare |
| v1 | 2019-08-06 | English | Compare |
Showing 1 to 3 of 3